eGFR vs CrCl: Which Renal Metric Should You Use?

By Jane Patel, MD — Board-certified internist with a focus on nephrology and contrast safety. Writes clinical explainers for Radcalcs.

Medically reviewed by Marcus Lee, MD (Diagnostic Radiology, 12 years) on July 28, 2026.

The Short Answer

Use eGFR (CKD-EPI 2021) for staging and contrast decisions. Use CrCl (Cockcroft-Gault) for drug dosing. They are not interchangeable — they estimate different things on different scales. The eGFR Calculator runs CKD-EPI; the CrCl Calculator runs Cockcroft-Gault with IBW/ABW adjustment.

One-sentence rule: eGFR answers "Does this patient fit the CKD grid?" — CrCl answers "How much drug or contrast is safe now?"

What Each Equation Measures

Both equations turn a single serum creatinine into a renal metric — but they estimate different physiologic quantities.

CKD-EPI 2021 (race-free)

Estimates true GFR normalized to 1.73 m² of body surface area, so one threshold grid applies regardless of body habitus. The 2021 update removed the race coefficient. Inputs are serum creatinine, age, and sex.

eGFR = 142 × min(SCr/κ, 1)^α × max(SCr/κ, 1)^-1.200 × 0.9938^age × 1.012 [if female]

Where κ is 0.7 (female) or 0.9 (male), and α is -1.200 (female) or -0.328 (male). Open the eGFR Calculator for the full implementation.

Cockcroft-Gault CrCl

Estimates creatinine clearance in absolute mL/min — what FDA dosing tables use. Weight is required, and the choice of actual vs ideal vs adjusted body weight meaningfully changes the result.

CrCl = [(140 − age) × weight(kg)] / (72 × SCr) × 0.85 [if female]

Replace actual weight with IBW (Devine formula) or ABW (IBW + 0.4 × (actual − IBW)) when the patient is small or obese — the CrCl Calculator applies these adjustments automatically.

For background on how these numbers change with age in healthy adults, see our normal eGFR by age explainer.

Side-by-Side Comparison

Despite being computed from the same serum creatinine, the two metrics differ in unit, required input, and intended use.

Feature	eGFR (CKD-EPI 2021)	CrCl (Cockcroft-Gault)
What it estimates	GFR normalized to 1.73 m² BSA	Creatinine clearance (absolute, unadjusted)
Output unit	mL/min/1.73m²	mL/min
Weight required	No	Yes (IBW/ABW for accuracy)
Normalized to BSA	Yes (built in)	No — apply BSA if comparing across body sizes
Best used for	CKD staging, contrast safety thresholds	Drug dosing (DOACs, antibiotics, chemotherapy)
Guideline endorsement	KDIGO, NKF, ACR contrast manual	FDA drug labels, pharmacokinetic studies
Normal range (adult)	≥ 60 mL/min/1.73m²	≥ 90 mL/min (drug-label threshold varies)

Decision Aid: Which Should You Use?

Three scenarios cover most bedside decisions when both metrics are available.

💊

Drug dosing → use CrCl (Cockcroft-Gault)

FDA-approved drug labels — including apixaban, rivaroxaban, dabigatran, vancomycin, aminoglycosides, and several chemotherapeutics — use CrCl cutoffs. CKD-EPI eGFR routinely overestimates clearance in small, female, or elderly patients and underestimates it in large or muscular patients, which translates to wrong doses either way.

🫘

CKD staging & contrast safety → use eGFR (CKD-EPI)

KDIGO stages G1–G5 against eGFR. ACR contrast thresholds (the 30 threshold for metformin hold and gadolinium NSF risk, the 5×CrCl ceiling when CrCl is the input) all map to eGFR-banded decisions. Use the eGFR Calculator to stage.

⚖️

eGFR and CrCl diverge substantially → check body habitus

When the two values disagree by more than ~20 mL/min, the cause is usually body composition: obesity pushes Cockcroft-Gault down (weight in numerator), low muscle mass pushes both up (less creatinine generation), and extremes of height change only CrCl. Recheck ABW/IBW choice, run cystatin C–based eGFR as a tie-breaker, and document which metric you read.

Unit Conversion Gotchas

The unit labels look similar — both say "mL/min" — but they are not equivalent. This is the single most common source of dosing and contrast-decision errors.

eGFR units: mL/min/1.73 m²

The denominator 1.73 m² is the standard adult body surface area. CKD-EPI normalizes to it so the result can be compared across patients of different sizes. It is not how much plasma this individual patient filters per minute — it is the volume a person with body surface area 1.73 m² would filter. Patients with BSA larger than 1.73 m² actually filter more plasma than their eGFR suggests; patients with BSA smaller than 1.73 m² filter less.

CrCl units: absolute mL/min

Cockcroft-Gault gives an absolute number — how much plasma this patient is estimated to clear. FDA labels assume this number. Drug-dosing tables use this number.

When the two values are closest

Average-size adults (BSA ≈ 1.73 m²) — the two values usually agree within 10–15%. As body habitus moves away from the standard, the gap widens. In patients with obesity or cachexia, do not substitute one for the other.

µmol/L vs mg/dL creatinine

Outside the US, creatinine is reported in µmol/L. The conversion is mg/dL × 88.4 = µmol/L. Both the eGFR Calculator and the CrCl Calculator accept either unit and convert internally.

Normal Ranges at a Glance

The "normal eGFR" used by most labs is ≥ 60 mL/min/1.73 m², but age-appropriate ranges run higher in younger patients and lower in older adults. For the full age curve, see our normal eGFR by age explainer.

Population	Typical eGFR	Comparable CrCl
Healthy young adult (20–30)	~90–120 mL/min/1.73m²	~95–130 mL/min
Healthy middle-aged adult (40–50)	~75–105 mL/min/1.73m²	~80–115 mL/min
Healthy older adult (70+)	~45–85 mL/min/1.73m²	~50–90 mL/min
CKD-stage threshold (KDIGO)	< 60 mL/min/1.73m² × 90d	— (not used for staging)
Drug-dose threshold (label-dependent)	—	e.g. 30, 50 mL/min cutoffs

Frequently Asked Questions

What is the difference between eGFR and CrCl?

eGFR is an estimate of glomerular filtration rate normalized to a standard body surface area of 1.73 m², so the result is comparable across body sizes and maps directly to KDIGO CKD stages. CrCl (creatinine clearance, Cockcroft-Gault) is the volume of plasma cleared of creatinine per minute in absolute mL/min — without BSA normalization. eGFR is the metric for staging and contrast decisions; CrCl is the metric for drug dosing.

Which equation should I use for drug dosing — eGFR or CrCl?

Use Cockcroft-Gault CrCl. Most FDA drug labels — DOACs (apixaban, rivaroxaban, dabigatran), aminoglycosides, vancomycin, several chemotherapeutics — list dose adjustments by CrCl cutoffs. eGFR is not interchangeable with CrCl because eGFR is normalized to 1.73 m² BSA; using eGFR in patients who are smaller or larger than the reference body size systematically over- or underestimates clearance.

When should I use CKD-EPI eGFR vs Cockcroft-Gault CrCl for contrast decisions?

Use CKD-EPI eGFR as the entry point — it maps to ACR contrast-safety thresholds (eGFR 30 for metformin hold, eGFR 30 for gadolinium NSF risk tiers, KDIGO stages for CKD severity). Switch to Cockcroft-Gault CrCl when a specific mL/min value drives the calculation, such as the 5×CrCl contrast volume ceiling — at that point the absolute mL/min number is the input, not an eGFR-banded decision.

Are eGFR and CrCl the same number?

No. They differ by 10–40 mL/min in the same patient depending on body habitus. eGFR is normalized to 1.73 m² BSA and does not use weight; CrCl uses actual or adjusted body weight. In average-size adults they track closely; in obesity, low muscle mass, pregnancy, or small body habitus they diverge substantially. Use the right one for the question you are answering — substituting eGFR into a drug-dose table, or CrCl into a CKD stage, will be wrong.

⚕️ Clinical Disclaimer: The information on this page is for educational purposes only. Renal-function interpretation and medication dosing must be individualized by qualified healthcare professionals in the context of the patient's full clinical picture. Radcalcs is not responsible for clinical decisions made based on this content.

References

Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C–Based Equations to Estimate GFR without Race. N Engl J Med. 2021;385(19):1737–1749.
Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16(1):31–41.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for CKD Evaluation and Management. Kidney Int. 2024;105(4):639–740.
American College of Radiology. ACR Manual on Contrast Media. 2024 edition.
Levey AS, Inker LA. Assessment of Glomerular Filtration Rate in Health and Disease: A State of the Art Review. Clin Pharmacol Ther. 2017;102(3):405–419.